<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv=Content-Type content="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 12 (filtered medium)">
<style>
<!--
/* Font Definitions */
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
        {mso-style-priority:1;
        margin:0in;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
.MsoChpDefault
        {mso-style-type:export-only;}
@page Section1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
        {page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=EN-US link=blue vlink=purple>
<div class=Section1>
<p class=MsoNormal><i>(Sorry for any cross postings)</i> We have recently
updated each state’s stance on EPI Salts and Nitroglycerin Formulations
document to include New York’s recent acceptance of the EPA’s
stance on Epinephrine Salts. Here’s a link to our website document
for all 50 states: <a
href="http://www.pharmwastetech.com/websitePDFs/State%20Regs(2).pdf">http://www.pharmwastetech.com/websitePDFs/State%20Regs(2).pdf</a><o:p></o:p></p>
<p class=MsoNormal>Supporting documentation for New York’s recent change
can be found at: <a
href="http://www.pharmwastetech.com/websitePDFs/NY%20Epi%20Salts.pdf">http://www.pharmwastetech.com/websitePDFs/NY%20Epi%20Salts.pdf</a><o:p></o:p></p>
<p class=MsoNoSpacing><o:p> </o:p></p>
<p class=MsoNoSpacing>Warmest Regards,<o:p></o:p></p>
<p class=MsoNormal><o:p> </o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>Jeff Hollar</span><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>President</span><o:p></o:p></p>
<p class=MsoNormal> <o:p></o:p></p>
<p class=MsoNormal><b><span style='color:blue'>PharmWaste Technologies, Inc.</span></b><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>4164 NW Urbandale
Dr., Suite A</span><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>Urbandale, IA
50322</span><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>(P) 515-276-5302
Ext. 316</span><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>(F) 480-393-5564</span><o:p></o:p></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>(E) <a
href="mailto:Jhollar@Pwaste.com"><span style='color:blue'>Jhollar@Pwaste.com</span></a><o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'>(W)
www.pwaste.com<o:p></o:p></span></p>
<p class=MsoNormal><span style='font-size:10.0pt;color:black'><o:p> </o:p></span></p>
<p class=MsoNormal><o:p> </o:p></p>
</div>
</body>
</html>